COMPASS Pathways Receivables 2019-2025 | CMPS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

COMPASS Pathways receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

COMPASS Pathways receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$143.6B
CVS Health (CVS)	$83.1B
Elevance Health (ELV)	$66.2B
Cencora (COR)	$55.3B
DiDi Global (DIDIY)	$26.1B
Labcorp Holdings (LH)	$22.1B
Natera (NTRA)	$20.7B
BioMerieux (BMXMF)	$17.7B
EUROFINS SCIENT (ERFSF)	$14.9B
CochLear (CHEOY)	$13.2B
ICON (ICLR)	$12.8B
Solventum (SOLV)	$12.7B
Medpace Holdings (MEDP)	$12.2B
Viatris (VTRS)	$11.4B
Revvity (RVTY)	$10.1B
Sonic Healthcare (SKHHY)	$9B
HealthEquity (HQY)	$8B
Avantor (AVTR)	$7.8B
Caris Life Sciences,�Inc (CAI)	$7.6B
Charles River Laboratories (CRL)	$7.3B
Bausch + Lomb (BLCO)	$4.8B
Sotera Health (SHC)	$4B
Amplifon S.p.A (AMFPF)	$3.9B
BrightSpring Health Services (BTSG)	$3.7B
Surgery Partners (SGRY)	$3B
GeneDx Holdings (WGS)	$3B
Alignment Healthcare (ALHC)	$2.9B
Concentras Parent (CON)	$2.8B
Organon (OGN)	$2.4B
Progyny (PGNY)	$2B